US halts plasma study to treat mild COVID-19 citing 'unlikely benefit'
March 04 2021, 08:00
The National Institutes of Health announced Tuesday it stopped a clinical trial testing convalescent plasma in mild-to-moderate COVID-19 patients after an independent board found no difference in hospitalizations, deaths or in preventing progression to severe illness.
The National Institutes of Health announced Tuesday it stopped a clinical trial testing convalescent plasma in mild-to-moderate COVID-19 patients after an independent board found no difference in hospitalizations, deaths or in preventing progression to severe illness.
Source:
FOX News